PhiChem Inkomsten in het verleden
Verleden criteriumcontroles 1/6
PhiChem's earnings have been declining at an average annual rate of -4.6%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 13% per year. PhiChem's return on equity is 3.2%, and it has net margins of 3.7%.
Belangrijke informatie
-4.6%
Groei van de winst
-5.2%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 12.1% |
| Inkomstengroei | 13.0% |
| Rendement op eigen vermogen | 3.2% |
| Nettomarge | 3.7% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe PhiChem geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 2,901 | 108 | 517 | 180 |
| 30 Jun 24 | 2,836 | 58 | 528 | 187 |
| 31 Mar 24 | 2,795 | 100 | 466 | 193 |
| 31 Dec 23 | 2,729 | 112 | 459 | 189 |
| 30 Sep 23 | 2,666 | 324 | 397 | 172 |
| 30 Jun 23 | 2,563 | 356 | 360 | 165 |
| 31 Mar 23 | 2,643 | 368 | 375 | 175 |
| 01 Jan 23 | 2,907 | 435 | 398 | 184 |
| 30 Sep 22 | 2,980 | 436 | 388 | 210 |
| 30 Jun 22 | 3,069 | 471 | 396 | 216 |
| 31 Mar 22 | 2,930 | 456 | 381 | 202 |
| 01 Jan 22 | 2,627 | 386 | 345 | 193 |
| 30 Sep 21 | 2,406 | 331 | 325 | 166 |
| 30 Jun 21 | 2,237 | 288 | 310 | 155 |
| 31 Mar 21 | 2,059 | 246 | 306 | 155 |
| 31 Dec 20 | 1,864 | 230 | 277 | 136 |
| 30 Sep 20 | 1,746 | 240 | 298 | 144 |
| 30 Jun 20 | 1,596 | 243 | 282 | 132 |
| 31 Mar 20 | 1,509 | 234 | 262 | 121 |
| 31 Dec 19 | 1,513 | 255 | 267 | 122 |
| 30 Sep 19 | 1,457 | 214 | 237 | 109 |
| 30 Jun 19 | 1,449 | 251 | 220 | 113 |
| 31 Mar 19 | 1,459 | 285 | 217 | 115 |
| 31 Dec 18 | 1,446 | 284 | 222 | 114 |
| 30 Sep 18 | 1,443 | 289 | 252 | 127 |
| 30 Jun 18 | 1,314 | 215 | 216 | 141 |
| 31 Mar 18 | 1,070 | 142 | 205 | 107 |
| 31 Dec 17 | 820 | 84 | 173 | 84 |
| 30 Sep 17 | 578 | 64 | 107 | 45 |
| 30 Jun 17 | 445 | 56 | 126 | 0 |
| 31 Mar 17 | 400 | 65 | 114 | 0 |
| 31 Dec 16 | 391 | 68 | 113 | 0 |
| 30 Sep 16 | 387 | 75 | 112 | 0 |
| 30 Jun 16 | 408 | 90 | 105 | 0 |
| 31 Mar 16 | 426 | 98 | 100 | 0 |
| 31 Dec 15 | 432 | 105 | 95 | 0 |
| 30 Sep 15 | 457 | 106 | 90 | 0 |
| 30 Jun 15 | 447 | 104 | 85 | 0 |
| 31 Mar 15 | 434 | 98 | 78 | 0 |
| 31 Dec 14 | 402 | 90 | 70 | 0 |
| 30 Sep 14 | 359 | 78 | 65 | 0 |
| 31 Dec 13 | 323 | 65 | 61 | 0 |
Kwaliteitswinsten: 300398 has high quality earnings.
Groeiende winstmarge: 300398's current net profit margins (3.7%) are lower than last year (12.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 300398's earnings have declined by 4.6% per year over the past 5 years.
Versnelling van de groei: 300398's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 300398 had negative earnings growth (-66.7%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).
Rendement op eigen vermogen
Hoge ROE: 300398's Return on Equity (3.2%) is considered low.